Annual EBITDA
-$49.26 M
-$4.26 M-9.47%
31 December 2023
Summary:
Hepion Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization is currently -$49.26 million, with the most recent change of -$4.26 million (-9.47%) on 31 December 2023. During the last 3 years, it has fallen by -$29.00 million (-143.16%). HEPA annual EBITDA is now -2848.20% below its all-time high of -$1.67 million, reached on 30 June 2014.HEPA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$4.46 M
+$4.05 M+47.57%
30 September 2024
Summary:
Hepion Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization is currently -$4.46 million, with the most recent change of +$4.05 million (+47.57%) on 30 September 2024. Over the past year, it has increased by +$6.19 million (+58.12%). HEPA quarterly EBITDA is now -4496.19% below its all-time high of -$97.00 thousand, reached on 30 September 2018.HEPA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$30.02 M
+$6.19 M+17.09%
30 September 2024
Summary:
Hepion Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization is currently -$30.02 million, with the most recent change of +$6.19 million (+17.09%) on 30 September 2024. Over the past year, it has increased by +$19.22 million (+39.03%). HEPA TTM EBITDA is now -16543.07% below its all-time high of -$180.40 thousand, reached on 30 September 2013.HEPA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HEPA EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.5% | +58.1% | +39.0% |
| 3 y3 years | -143.2% | +51.8% | -7.8% |
| 5 y5 years | -411.6% | -148.1% | -288.6% |
HEPA EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -143.2% | at low | at high | +77.6% | -7.8% | +43.1% |
| 5 y | 5 years | -568.9% | at low | -148.1% | +77.6% | -307.7% | +43.1% |
| alltime | all time | -2848.2% | at low | -4496.2% | +77.6% | <-9999.0% | +43.1% |
Hepion Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.46 M(-47.6%) | -$30.02 M(-17.1%) |
| June 2024 | - | -$8.50 M(+46.9%) | -$36.21 M(-13.5%) |
| Mar 2024 | - | -$5.79 M(-48.7%) | -$41.86 M(-15.1%) |
| Dec 2023 | -$49.26 M(+9.5%) | -$11.27 M(+5.9%) | -$49.31 M(+0.1%) |
| Sept 2023 | - | -$10.65 M(-24.7%) | -$49.24 M(+4.7%) |
| June 2023 | - | -$14.15 M(+6.9%) | -$47.04 M(-10.9%) |
| Mar 2023 | - | -$13.24 M(+18.1%) | -$52.79 M(+13.6%) |
| Dec 2022 | -$45.00 M(+37.9%) | -$11.21 M(+32.7%) | -$46.45 M(+3.4%) |
| Sept 2022 | - | -$8.45 M(-57.5%) | -$44.94 M(-1.7%) |
| June 2022 | - | -$19.89 M(+188.1%) | -$45.73 M(+36.6%) |
| Mar 2022 | - | -$6.90 M(-28.8%) | -$33.49 M(+2.6%) |
| Dec 2021 | -$32.63 M(+61.1%) | -$9.70 M(+4.9%) | -$32.63 M(+17.1%) |
| Sept 2021 | - | -$9.24 M(+20.9%) | -$27.86 M(+12.0%) |
| June 2021 | - | -$7.64 M(+26.5%) | -$24.89 M(+12.7%) |
| Mar 2021 | - | -$6.04 M(+22.6%) | -$22.08 M(+9.0%) |
| Dec 2020 | -$20.26 M(+175.1%) | -$4.93 M(-21.4%) | -$20.26 M(+15.9%) |
| Sept 2020 | - | -$6.27 M(+29.6%) | -$17.48 M(+34.4%) |
| June 2020 | - | -$4.84 M(+14.6%) | -$13.01 M(+34.1%) |
| Mar 2020 | - | -$4.22 M(+95.9%) | -$9.70 M(+31.8%) |
| Dec 2019 | -$7.36 M | -$2.15 M(+19.9%) | -$7.36 M(-4.7%) |
| Sept 2019 | - | -$1.80 M(+17.3%) | -$7.73 M(+28.2%) |
| June 2019 | - | -$1.53 M(-18.6%) | -$6.03 M(-27.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$1.88 M(-25.3%) | -$8.29 M(-19.3%) |
| Dec 2018 | -$9.63 M(-8.4%) | -$2.52 M(+2494.1%) | -$10.26 M(+32.5%) |
| Sept 2018 | - | -$97.00 K(-97.4%) | -$7.75 M(-42.5%) |
| June 2018 | - | -$3.79 M(-1.7%) | -$13.48 M(-9.5%) |
| Mar 2018 | - | -$3.86 M(-33.9%) | -$14.90 M(-32.1%) |
| Dec 2017 | -$10.51 M(-49.9%) | - | - |
| Sept 2017 | - | -$5.83 M(+12.0%) | -$21.96 M(+4.6%) |
| June 2017 | -$21.00 M(+1.0%) | -$5.21 M(+6.3%) | -$21.00 M(-2.7%) |
| Mar 2017 | - | -$4.90 M(-18.6%) | -$21.57 M(+1.2%) |
| Dec 2016 | - | -$6.02 M(+23.5%) | -$21.32 M(+2.4%) |
| Sept 2016 | - | -$4.87 M(-15.9%) | -$20.81 M(+0.1%) |
| June 2016 | -$20.78 M(+49.1%) | -$5.79 M(+24.6%) | -$20.78 M(+2.1%) |
| Mar 2016 | - | -$4.65 M(-15.6%) | -$20.37 M(+1.3%) |
| Dec 2015 | - | -$5.51 M(+13.8%) | -$20.11 M(+13.6%) |
| Sept 2015 | - | -$4.84 M(-9.9%) | -$17.70 M(+27.0%) |
| June 2015 | -$13.94 M(+734.5%) | -$5.37 M(+22.2%) | -$13.94 M(+47.7%) |
| Mar 2015 | - | -$4.39 M(+41.7%) | -$9.44 M(+71.4%) |
| Dec 2014 | - | -$3.10 M(+187.1%) | -$5.51 M(+114.3%) |
| Sept 2014 | - | -$1.08 M(+24.4%) | -$2.57 M(+53.8%) |
| June 2014 | -$1.67 M | -$868.20 K(+89.2%) | -$1.67 M(+108.2%) |
| Mar 2014 | - | -$459.00 K(+181.1%) | -$802.70 K(+133.5%) |
| Dec 2013 | - | -$163.30 K(-9.5%) | -$343.70 K(+90.5%) |
| Sept 2013 | - | -$180.40 K | -$180.40 K |
FAQ
- What is Hepion Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual EBITDA year-on-year change?
- What is Hepion Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Hepion Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM EBITDA year-on-year change?
What is Hepion Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of HEPA is -$49.26 M
What is the all time high annual EBITDA for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.67 M
What is Hepion Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, HEPA annual earnings before interest, taxes, depreciation & amortization has changed by -$4.26 M (-9.47%)
What is Hepion Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of HEPA is -$4.46 M
What is the all time high quarterly EBITDA for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$97.00 K
What is Hepion Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, HEPA quarterly earnings before interest, taxes, depreciation & amortization has changed by +$6.19 M (+58.12%)
What is Hepion Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of HEPA is -$30.02 M
What is the all time high TTM EBITDA for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is -$180.40 K
What is Hepion Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, HEPA TTM earnings before interest, taxes, depreciation & amortization has changed by +$19.22 M (+39.03%)